Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease | Zendy

Eva Lonn | Zendy; Jackie Bosch | Zendy; Patricio LópezJaramillo | Zendy; Jun Zhu | Zendy; Lisheng Liu | Zendy; Prem Pais | Zendy; Rafael Díaz | Zendy; Denis Xavier | Zendy; Karen Sliwa | Zendy; Antonio Dans | Zendy; Álvaro Avezum | Zendy; Leopoldo Soares Piegas | Zendy; Katalin Keltai | Zendy; Matyàs Keltai | Zendy; И Е Чазова | Zendy; Ron J.G. Peters | Zendy; Claes Held | Zendy; Khalid Yusoff | Zendy; Basil S. Lewis | Zendy; Petr Jánský | Zendy; Alexander Parkhomenko | Zendy; Kamlesh Khunti | Zendy; William D. Toff | Zendy; Christopher M. Reid | Zendy; George Varigos | Zendy; Lawrence A. Leiter | Zendy; Dora I. Molina | Zendy; Robert S. McKelvie | Zendy; Janice Pogue | Zendy; James D. Wilkinson | Zendy; Hyejung Jung | Zendy; Gilles R. Dagenais | Zendy; Salim Yusuf | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

Author(s) -

Eva Lonn,

Jackie Bosch,

Patricio LópezJaramillo,

Jun Zhu,

Lisheng Liu,

Prem Pais,

Rafael Díaz,

Denis Xavier,

Karen Sliwa,

Antonio Dans,

Álvaro Avezum,

Leopoldo Soares Piegas,

Katalin Keltai,

Matyàs Keltai,

И Е Чазова,

Ron J.G. Peters,

Claes Held,

Khalid Yusoff,

Basil S. Lewis,

Petr Jánský,

Alexander Parkhomenko,

Kamlesh Khunti,

William D. Toff,

Christopher M. Reid,

George Varigos,

Lawrence A. Leiter,

Dora I. Molina,

Robert S. McKelvie,

Janice Pogue,

James D. Wilkinson,

Hyejung Jung,

Gilles R. Dagenais,

Salim Yusuf

Publication year - 2016

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1600175

Subject(s) - medicine , blood pressure , hazard ratio , myocardial infarction , placebo , confidence interval , cardiology , alternative medicine , pathology

Antihypertensive therapy reduces the risk of cardiovascular events among high-risk persons and among those with a systolic blood pressure of 160 mm Hg or higher, but its role in persons at intermediate risk and with lower blood pressure is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research